Global Asthma and COPD Drug Market – Size, Share and Forecast (2019-2026)

SKU: DPH14 | Published On: | Available Formats

Asthma and COPD Drug Market

  • Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that make it difficult to breathe. COPD can include emphysema and chronic bronchitis.
  • The medications that can help reduce inflammation and open the airways to help breathe easier with COPD include; short-acting bronchodilators, corticosteroids, methylxanthines, long-acting bronchodilators, combination drugs, and roflumilast.
  • Asthma is a chronic disease that makes breathing difficult. Asthma is an inflammation of the air passages in a temporary narrowing of the airways that carry oxygen to the lungs.
  • The medications for asthma include; inhaled corticosteroids, short-acting beta agonists, immunotherapy, omalizumab, and others.
  • Global asthma and COPD drug market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.

 

Asthma and COPD Drug Market Dynamics

  • The rising prevalence of chronic diseases is one of the factors fueling global asthma and COPD drug market.
  • According to the Centers for Disease Control and Prevention (CDC), in 2017, 19.9 million adults aged 18 and over have asthma. About 1 in 12 people have asthma, and the numbers are increasing every year.
  • According to the American Academy of Allergy, Asthma & Immunology, in 2016, approximately 8.3% of children in the United States had asthma. Boys were slightly more likely to have asthma than girls at a rate of 9.2% and 7.4%, respectively.
  • In 2016, there were 3,615 asthma-related deaths in 2015. Children under 18 years old made up 219 of those deaths.
  • According to Asthma UK, 5.4 million people in the UK have asthma, which is 1.1 million children and 4.3 million adults in 2016. In 2016 1,410 people died from asthma. In England, 4,500,000 people (1 in 11) have asthma. This consists of 932,000 children and 3,600,000 adults.
  • The UK has among the highest prevalence rates of asthma symptoms in children worldwide.
  • According to Asthma Australia, 1 in 9 Australians has asthma, which is around 2.7 million people with asthma. In 2015, 11.2% of Australians had asthma.
  • According to the World Health Organization (WHO), More than 65 million people around the world have moderate or severe COPD. The prevalence of COPD increased by 44.2 percent to 174.5 million individuals globally. COPD is a leading cause of death in the United States, affecting 16 million Americans in 2015.

 

Asthma and COPD Drug Market Segmentation Analysis

  • Based on drug type, the global market for asthma and COPD drug is broadly segmented as by combination drugs, leukotriene antagonists (LTA), inhaled corticosteroids (ICS), anticholinergics, short-acting beta agonists (SABA), long-acting beta agonists (LABA), and others.
  • Currently, combination drugs are the dominant segment, and it accounts for approximately XX% of the market, due to the regulatory approval for combination drugs.
  • For instance, in September 2017, GlaxoSmithKline plc and Innoviva, Inc. have received the US Food and Drug Administration (FDA) has approval for single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trilogy Ellipta, with combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in addition treatment of airflow obstruction.
  • In April 2016, AstraZeneca received the US Food and Drug Administration approval for BEVESPI AEROSPHERE (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). BEVESPI atmosphere is a combination of glycopyrrolate, an anticholinergic, and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA).
  • In May 2015, Boehringer Ingelheim received the U.S. Food and Drug Administration (FDA) has approval for a new medication, Sciolto Respimat, to treat chronic obstructive pulmonary disease (COPD), combines two different existing COPD drugs with complementary effects into a once-a-day inhaler.


 

Asthma and COPD Drug Market Geographical Analysis

  • Global asthma and COPD drug market are segmented into North America, Europe, Asia Pacific, South America, and ROW.
  • North America is dominating global asthma and COPD drug market, due to the regulatory approval and expansion of product portfolio by adding asthma and COPD drug, which is fueling the market growth.
  • For instance, in February 2019, Mylan has received the U.S. Food and Drug Administration (FDA) approval for first generic version of Advair Diskus (fluticasone propionate and salmeterol inhalation powder).
  • In October 2018, Regeneron Pharmaceuticals, Inc. and Sanofi, have received the U.S. Food and Drug Administration approval for Dupixent (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.
  • In January 2015, GlaxoSmithKline plc expanded its portfolio of in the US, for patients with asthma and COPD. The add-on portfolio includes Arnuity Ellipta and Incruse Ellipta.

 

Asthma and COPD Drug Market Competitive Analysis

  • The strategic alliance between companies and regulatory approval for asthma and COPD drug is one of the critical factor driving global asthma and COPD drug market.
  • For instance, in December 2018, Teva Pharmaceutical Industries Ltd. have received the U.S. Food and Drug Administration (FDA) approval for ProAir Digital (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which connects to a companion mobile application and provides inhaler use information to people with asthma and COPD.
  • In September 2017, Pulmatrix, Inc. partnered with Vectura Group plc to develop Pulmatrix’s drug, PUR0200, for chronic obstructive pulmonary disease (COPD) for the U.S. market.
  • In May 2016, Vectura Group plc and Propeller Health, have collaborated to develop inhalers that combine Vectura’s proven dry powder inhaler (“DPI”) technology with Propeller’s digital health platform.

 

Why Purchase the Report?

• Visualize the composition of asthma and COPD drug market across each indication, in terms of drug type, highlighting the critical commercial assets and players.

• Identify business opportunities in asthma and COPD drug market by analyzing trends and co-development deals.

• Excel data sheet with thousands of data points of asthma and COPD drug market – level 4/5 segmentation.

• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

• Product mapping in excel for the principal products of all major market players

 

Target Audience

• Equipment Suppliers/ Buyers

• Service Providers/ Buyers

• Industry Investors/Investment Bankers

• Education & Research Institutes

• Research Professionals

• Emerging Companies

• Manufacturers

Global Asthma and COPD Drug Market

1. Asthma and COPD Drug Market Scope and Methodology

1.1. Research Methodology

1.2. Scope of the market 

2. Asthma and COPD Drug Industry Trends

2.1. Key Market Trends and Developments in Asthma and COPD Drug Market

3. Asthma and COPD Drug Market Outlook

3.1. Drivers

3.2. Restraints

3.3. Opportunity

3.4. Pricing Analysis

3.5. Regulation

3.6. Supply Chain Analysis

3.7. Reimbursement policies

3.8. Technological Advancements

3.9. PEST analysis

3.10. Porter’s Five Forces Analysis 

4. Market Segmentation Analysis

4.1. BY DRUG TYPE

4.1.1. Combination Drugs

4.1.2. Leukotriene antagonists (LTA)

4.1.3. Inhaled corticosteroids (ICS)

4.1.4. Anticholinergics

4.1.5. Short acting beta agonists (SABA)

4.1.6. Long acting beta agonists (LABA)

4.1.7. Others

5. Regional, Country-level Analysis

5.1. Geographic Overview

5.2. North America

5.2.1. The U.S.

5.2.2. Mexico

5.2.3. Canada

5.3. Europe

5.3.1. Germany

5.3.2. The U.K.

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Rest of Europe

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. Asia Pacific

5.5.1. China

5.5.2. India

5.5.3. Japan

5.5.4. Australia

5.5.5. Rest of Asia Pacific

5.6. Rest of World

6. Competitive Analysis

6.1. Competitive Scenario

6.2. Heat Map Analysis

6.3. Product Benchmarking 

7. Company Profiles

7.1. Boehringer Ingelheim International GmbH

7.2. Merck & Co., Inc.

7.3. GlaxoSmithKline PLC.

7.4. Novartis AG

7.5. AstraZeneca

7.6. F. Hoffmann-La Roche Ltd

7.7. Teva Pharmaceutical Industries Ltd.

7.8. Vectura Group plc.

7.9. Pfizer, Inc.

7.10. Abbott Laboratories

8. Key companies to watch

9. Emerging Companies

10. Appendix

10.1. Sources

10.2. List of Tables

10.3. Expert Panel Validation

10.4. Disclaimer

10.5. Contact Us

Buy This Report



Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports

DMI Cognizance Expertise

Massive Repository

10-year historic data for 1000+ markets

Association Networks

Ground-Zero understanding of the market with inputs from relevant industry association members

First Hand Understanding

Tailored interviews with manufacturers, buyers, sellers, distributers and retailers for five-frame understanding of the market

360 Web Research

Analysis of publicly available white label papers, news announcements, press releases, financial reports and reliable paid consulting data

Star Expert Review

7-step data formulation for market analysis and forecasts, under thorough scrutiny of industry-specific consultants with over 20+ years of expertise

INSTANT DELIVERY - 20% OFF

Global Voice Restoration Devices Market – Size, Share and Forecast (2018 – 2025)

Global Breast Implant Market – Size, Share and Forecast (2018 – 2025)

Global Continuous Glucose Monitoring Market – Size, Share and Forecast (2019 – 2026)

Global Tabular Alumina Market – Size, Share and Forecast (2019-2025)

Global Continuous Passive Movement Market – Size, Share and Forecast (2019-2026)

Europe Specialty Tires Market – Size, Share and Forecast (2019-2026)

Europe Phase Change Material Market – Size, Share and Forecast (2019-2026)

Global Forage Seed Market – Size, Share and Forecast (2018-2025)

Global Bio-lubricants market – Size, Trends, Share and Forecast (2018-2025)

Global Genome Editing Market – Size, Share and Forecast (2018-2025)

Global Perlite Market – Size, Share and Forecast (2018-2025)

Global Diagnostic Imaging Market – Size, Share and Forecast (2018-2025)

Indonesia Flexible Packaging Market – Size, Share and Forecasts (2018-2025)

Global Fiber Cement Market – Size, Share and Forecast (2019-2026)

Global Hematology Market – Size, Share and Forecast ( 2018-2025 )

Global Utility Tractor Market – Size, Share and Forecast (2018 – 2025)

Global Smart Transformers Market – Size, Share and Forecast ( 2018 – 2025 )

Global Carbon Nanotubes Market – Size, Share and Forecast (2019-2026)

Global Food & Beverage Processing Equipment Market – Size, Share and Forecast (2018 – 2025)

Europe Construction Chemicals Market – Size, Share and Forecast (2018 – 2025)

Global Powered Exoskeleton Market – Size, Share and Forecast (2018-2025)

Global Desalination Market – Size, Share and Forecast (2018-2025)

Global Advanced Wound Care Market – Size, Share and Forecast (2018-2025)

Global Agrifood Blockchain Market – Size, Share and Forecast (2018-2025)

Global Bio fuels Market – Size, Share and Forecast (2018-2025)

Global Flexible Packaging Market – Size, Share and Forecast (2018-2025)

Global Hydrogen Cyanide Market – Size, Share and Forecast (2018-2026)

Global Companion Animal Health Market – Forecasts 2018-2025

Global Agricultural Tires Market – Size, Share and Forecast ( 2018-2025 )

Global Combined Heat and Power Market – Size, Share and Forecast (2018-2025)

Global Hemodialysis Market – Size, Share and Forecast (2018-2025)

Global Service Robotics Market – Size, Share and Forecast (2018-2025)

Global Closed System Drug Transfer Devices Market – Size, Share and Forecast (2018-2025)

Global 3D Printed Electronics Market – Size, Share and Forecast (2018-2025)

Global Feed Phosphate Market – Size, Share and Forecast (2019-2026)

Brazil Renal Dialysis Equipment Market – Size, Share and Forecast (2019-2026)

Global Cable Glands Market – Size, Share and Forecast (2019-2026)

Brazil Companion Animal Health Market – Size, Share and Forecast (2019-2026)

Global Diabetic Foot Ulcers Market – Size, Share and Forecasts (2019-2026)

Global Prostate Cancer Market – Size, Share and Forecasts (2019-2026)

Global Fetal Neonatal Monitoring Market – Size, Share and Forecast (2019-2026)

Global Stevia Market – Size,Share and Forecasts (2018-2025)

Brazil Diagnostic Imaging Market – Size, Share and Forecasts (2019-2026)

Philippines Contact Cement Market – Size, Share and Forecasts (2018-2025)

Global Central Venous Catheters Market – Size, Share and Forecast (2018-2025)

Global Atopic Dermatitis Market – Size, Share and Forecast (2018-2025)

Advanced Driver Assistance Systems Market – Size, Share and Forecast (2018-2025)

Global Oncolytic Virus Therapy Market – Size, Share and Forecast (2019-2026)

Global Diesel Generator Market – Size, Share and Forecast (2018-2025)

Global Animal Feed Additives Market – Size,Share and Forecast (2018-2025)

Agricultural Testing Market – Size, Share and Forecast (2018-2025)

Global Polyvinyl Chloride Market – Size, Share and Forecasts (2018-2025)

Plant Bio-Stimulants Market – Size, Share and Forecast (2018-2025)

Global Construction Chemicals Market – Size, Share and Forecasts (2018-2025)

Global Plant Proteins Market – Size, Share and Forecast (2018-2025)

Global Dairy Protein Market – Size, Share and Forecast (2018-2025)

Global Freeze-Dried Food Market – Size, Share and Forecasts (2018-2025)

Global Pet Food Market – Size, Share and Forecasts (2018-2025)

Global Respiratory Devices Market – Size, Share and Forecasts (2018-2025)

Global Pediatric Clinical Trails Market – Size, Share and Forecast (2018-2025)

Global ECG Market – Size, Share and Forecast (2018-2025)

Global Companion Diagnostics Market – Size, Share and Forecast (2018-2025)

Global Molecular Diagnostics Market – Size, Share and Forecast (2018-2025)

Food & Feed Testing and Certification – Size, Share and Forecast (2018-2025)

Global Active Pharmaceutical Ingredients Market – Size, Share and Forecast (2018-2025)

South America Companion Animal Healthcare Market – Size, Share and Forecast (2018-2025)

India Agriculture and Construction Equipment Market – Size, Share and Forecast (2019-2026)

Lubricants Market – Size,Share and Forecasts (2019-2026)

Global Graphene Market – Size, Share and Forecast (2019-2026)

Brazil Agricultural and Construction Equipment Market – Size, Share and Forecast (2019-2026)

Global Carbon Black Market – Size, Share and Forecasts (2019-2026)

China Companion Animal Health Market – Size, Share and Forecast (2018-2025)

India Truck and Bus Market – Size, Share and Forecast (2019-2026)

Brazil Truck & Bus Market – Size, Share and Forecast (2019-2026)

Global Photonics Market – Size, Share and Forecast (2019-2026)

Romania Agricultural Tractor Machinery Market – Size, Share and Forecast (2019-2026)

Inflight Catering Services – Size, Share and Forecast (2018-2025)

Global Arthroscopy Devices Market – Size, Share and Forecast (2018 – 2025)

Copyright © 2019 DataM Intelligence. All Rights Reserved

Designed and Developed by -Montaigne Labs